abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

이 페이지는 한국어로 제공되지 않으며 English로 표시됩니다.

기사

2007년 2월 12일

저자:
Nopporn Wong-Anan, Reuters

Thailand threatens to produce more copycat drugs

Thailand, which has upset big drug companies by issuing patent-overriding licences for generic versions of heart and HIV/AIDS pills, said on Monday it would issue more unless the firms cut prices... Last week, the Health Ministry issued compulsory licences for the heart disease drug Plavix, made by Bristol-Myers Squibb and Sanofi-Aventis, and Abbott Laboratories' Kaletra to treat HIV/AIDS. The licences...drew praise from AIDS activists, but flak from Washington and the drug industry, which are urging the ministry to rescind them. [also refers to drugs owned by Genentech, Biogen Idec]

타임라인